Dr. Nashib Hashmi, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 401 N Wall St, Suite 100, Kankakee, IL 60901 Phone: 815-932-7110 Fax: 815-932-7112 |
Dr. Miguel Hizon, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 455 W Court St, Ste 304, Kankakee, IL 60901 Phone: 815-933-4422 Fax: 815-933-4446 |
News Archive
Omecamtiv mecarbil, a cardiac myosin-activator, did not achieve its primary efficacy endpoint in reducing dyspnoea (shortness of breath) in patients with acute heart failure, according to the results of the phase II ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure) study.
Cell Therapeutics, Inc. (CTI) today announced that it has received notification from the U.S. Food and Drug Administration (FDA) that the partial clinical hold on tosedostat (IND 075503) has been removed and all studies underway may continue.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that at approximately $120 million, the hepatitis C virus drug market in Brazil is among the largest emerging pharmaceutical markets for the disease.
Researchers at Carnegie Mellon University have developed a method for tracking the locations of multiple individuals in complex, indoor settings using a network of video cameras, creating something similar to the fictional Marauder's Map used by Harry Potter to track comings and goings at the Hogwarts School.
› Verified 7 days ago